当前位置: X-MOL 学术Int. J. Environ. Res. Public Health › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
The Economic Burden of Cancers Attributable to Infection in the Republic of Korea: A Prevalence-Based Study
International Journal of Environmental Research and Public Health Pub Date : 2020-10-19 , DOI: 10.3390/ijerph17207592
Thi Xuan Trinh Nguyen , Minji Han , Moran Ki , Young Ae Kim , Jin-Kyoung Oh

Infection is a major cause of cancers. We estimated the economic burden of cancers attributable to infection in 2014 in Korea, where cancer causing infection is prevalent, but the economic burden of it has never been examined. Cancer patients were defined as those having made medical claims as recorded by the National Health Insurance Service, which is a mandatory insurance for all citizen. We multiplied the costs by the population-attributable fraction for each type of cancer. The study included direct and indirect costs, where direct costs comprised direct medical and non-medical costs of inpatients and outpatients, while indirect costs were estimated by identifying future income loss due to premature death, productivity loss during hospitalization/outpatient visits, and job loss. In 2014, there were 100,054 infection-related cancer patients, accounting for 10.7% of all Korean cancer cases for that year. Direct costs of cancers associated with infection stood at nearly USD 676.9 million, while indirect costs were much higher at USD 2.57 billion. The average expenditure of a typical patient was USD 32,435. Economic burden of cancers attributable to infection is substantial in Korea, accounting for 0.23% of the national gross domestic product and 1.36% of national healthcare expenditure in 2014.

中文翻译:

大韩民国可归因于癌症的癌症的经济负担:基于患病率的研究

感染是癌症的主要原因。我们估计了2014年韩国因感染引起的癌症的经济负担,在韩国,引起感染的癌症非常普遍,但从未对其经济负担进行过研究。癌症患者被定义为根据国家健康保险局(National Health Insurance Service)记录提出医疗要求的患者,这是所有公民的强制性保险。我们将每种癌症的费用乘以人群可归因的比例。该研究包括直接和间接费用,其中直接费用包括住院和门诊患者的直接医疗费用和非医疗费用,而间接费用是通过确定由于过早死亡,住院/门诊就诊期间的生产力损失和工作损失而导致的未来收入损失来估算的。 。2014年,有100,054位与感染相关的癌症患者,占当年韩国所有癌症病例的10.7%。与感染相关的癌症的直接成本接近6.769亿美元,而间接成本则高得多,达到25.7亿美元。典型患者的平均支出为32,435美元。在韩国,可归因于感染的癌症的经济负担很大,占2014年国民生产总值的0.23%和国民医疗保健支出的1.36%。
更新日期:2020-10-19
down
wechat
bug